U.S., Nov. 19 -- An application to own the trademark for 'CDAC' has been filed on Mar. 31, 2025.
Owner(s):
BEONE MEDICINES I GMBH; AESCHENGRABEN 27, , SWITZERLAND
Goods and/or Services:
For: Pharmaceutical products development relevant to Chimeric Degradation Activation Compounds; Scientific and technological research relating to Chimeric Degradation Activation Compounds; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; platform as a service (PAAS) featuring computer software platforms for scientific research information in the field of pharmaceuticals and clinical trials
Class(es): 100, 101
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=...